OAS1 Antibodies

Santa Cruz Biotechnology features a diverse variety of OAS1 monoclonal antibodies for research focused on understanding OAS1 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). OAS1, or 2',5'-oligoadenylate synthetase 1, is a crucial enzyme involved in the innate immune response, particularly in the detection and degradation of viral RNA. By synthesizing 2',5'-oligoadenylates, OAS1 activates RNase L, leading to the degradation of viral RNA and the inhibition of viral replication. Understanding OAS1 function is essential for developing therapeutic strategies against viral infections and for advancing knowledge of immune system regulation. Research utilizing OAS1 monoclonal antibodies has revealed significant insights into antiviral defense mechanisms. Scientists continue to uncover new aspects of OAS1's role in cellular immunity through various experimental approaches. Recent studies have highlighted OAS1's importance in multiple pathways beyond viral defense. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of immune system regulation and viral defense mechanisms.